User profiles for Julia Chalaye
julia chalayepraticien hospitalier, hopital henri mondor Verified email at hmn.aphp.fr Cited by 1544 |
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular …
…, A Bouvier, L Vervueren, J Chalaye… - The Lancet …, 2017 - thelancet.com
Background Sorafenib is the recommended treatment for patients with advanced hepatocellular
carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective …
carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of selective …
Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01 …
E Garin, L Tselikas, B Guiu, J Chalaye… - The lancet …, 2021 - thelancet.com
Background All randomised phase 3 studies of selective internal radiation therapy for advanced
hepatocellular carcinoma published to date have reported negative results. However, …
hepatocellular carcinoma published to date have reported negative results. However, …
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma
J Chalaye, CE Costentin, A Luciani, G Amaddeo… - Journal of …, 2018 - Elsevier
Background & Aims Hepatocellular carcinoma (HCC) staging according to the Barcelona
Clinical Liver Cancer (BCLC) classification is based on conventional imaging. The aim of our …
Clinical Liver Cancer (BCLC) classification is based on conventional imaging. The aim of our …
[18F]-NaF PET/CT imaging in cardiac amyloidosis
…, E Evangelista, M Sasanelli, J Chalaye… - Journal of nuclear …, 2016 - Springer
Cardiac amyloidosis (CA) is recognized as a common cause of restrictive cardiomyopathy
and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We …
and heart failure due to the deposition of insoluble proteins in the myocardial interstitium. We …
[HTML][HTML] 18F-FDG PET/CT predicts microvascular invasion and early recurrence after liver resection for hepatocellular carcinoma: a prospective observational study
Background This study assessed the prognostic value of 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET)/computed tomography (CT) in the prediction of MVI …
positron emission tomography (PET)/computed tomography (CT) in the prediction of MVI …
Major impact of personalized dosimetry using 90Y loaded glass microspheres SIRT in HCC: Final overall survival analysis of a multicenter randomized phase II study …
516 Background: 90Y loaded microsphere SIRT (radioembolization) is a treatment option in
advanced HCC. However, no personalized dosimetric endpoints are currently used. The …
advanced HCC. However, no personalized dosimetric endpoints are currently used. The …
[HTML][HTML] Health-related quality of life in locally advanced hepatocellular carcinoma treated by either radioembolisation or sorafenib (SARAH trial)
Background The aim of this ancillary study of the SARAH trial is to compare health-related
quality of life (HRQoL) in patients with locally advanced or inoperable hepatocellular …
quality of life (HRQoL) in patients with locally advanced or inoperable hepatocellular …
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable …
Objectives To compare the performance of the quantitative analysis of the hepatobiliary phase
(HBP) tumor enhancement in gadobenate dimeglumine (Gd-BOPTA)–enhanced MRI and …
(HBP) tumor enhancement in gadobenate dimeglumine (Gd-BOPTA)–enhanced MRI and …
Hepatocellular carcinomas with mutational activation of beta-catenin require choline and can be detected by positron emission tomography
Background & Aims In one-third of hepatocellular carcinomas (HCCs), cancer cells have
mutations that activate β-catenin pathway. These cells have alterations in glutamine, bile, and …
mutations that activate β-catenin pathway. These cells have alterations in glutamine, bile, and …
Chest PET/MRI in Solid Cancers: Comparing the Diagnostic Performance of a Free‐Breathing 3D‐T1‐GRE Stack‐of‐Stars Volume Interpolated Breath‐Hold …
…, B Emsen, A Monnet, J Chalaye… - Journal of Magnetic …, 2022 - Wiley Online Library
Background Whole‐body positron emission tomography/magnetic resonance imaging (WB‐PET/MRI)
is increasingly used in oncology. However, chest staging remains challenging. …
is increasingly used in oncology. However, chest staging remains challenging. …